Evaluation of the Clinical Efficacy and Safety of a Spot-on Combination of Imidacloprid 10%/ Moxidectin 2.5% (Advocate(R), Advantage(R) Multi) in Comparison to an Untreated control Group in the Treatment of Capillaria boehmi in Naturally Infected Dogs
DATE » 25.07.2017
AUTHORS » Fabrizia Veronesi, Angela Di Cesare, Gabriele Braun, Lisa Günther, Guilia Morganti, Fabrizio Rueca, Gabriele Petry, Roland Schaper, Donato Traversa